Additionally, blocking receptor-mediated endocytosis with a megalin inhibitor retained fetuin-A in the proximal tubule, protecting the kidneys from nephrocalcinosis in parathyroid hormone-treated rats [41]. Here, LRP2 is linked to nephrocalcinosis.